WuXi AppTec, Leading China-based CRO, Chooses CAS SciFinder(R) to Advance its R&D Competitiveness

By Chemical Abstracts Service, PRNE
Sunday, November 7, 2010

SHANGHAI, November 8, 2010 - Chemical Abstracts Service (CAS), the world's authority for chemical
information, announced today that WuXi AppTec, the leading China-based
contract research organization (CRO), has signed a contract to provide
SciFinder for all scientists within their organization. In 2009, a CAS
analysis of chemical literature showed that China led all nations in chemical
patent publications and was surging in output of journal literature. WuXi
AppTec is convincing proof of the continuous investment and ambition of
China-based corporations to lead the world market in the field of chemical

Scientists recognize SciFinder as the first choice for searching and
retrieving chemistry and related scientific information. With streamlined
navigation, an intuitive interface, and secure access to CAS content,
SciFinder makes it simple to quickly find the right information to support
research and make decisions with confidence. "We are pleased to select
SciFinder to advance our R&D competitiveness. As a knowledge-based,
problem-solving provider of broad chemistry-based services, WuXi will have
instant access to more than 10,000 journals and 61 patent authorities, using
an intuitive interface to seek out the latest in state-of-the-art research in
addition to the wealth of a century of scientific information, thereby
enabling our scientific team to more effectively address our customers' needs
in chemistry R&D," commented Dr. Ge Li, chairman and CEO of WuXi AppTec.

China's pharmaceutical market is growing rapidly. In the last decade,
Chinese invention applications increased by nearly 1,400 percent, with much
of that growth taking place in the pharmaceutical sector. More than half of
the Chinese patent applications during this period were from inventors within
China, which indicates that Chinese scientists now also recognize the
importance of monetizing research discoveries. "CAS has served chemists and
other scientists for more than 100 years. We are honored to share our
long-standing experience and comprehensive resources with WuXi AppTec, and
also to be part of the advancement of pharmaceutical discovery and innovation
in China, the fastest growing market in the world," said Robert Massie,
president of CAS.

CAS has already built a solid relationship with hundreds of Chinese
companies and multinational corporations operating in China, along with more
than 80 key universities and research institutions. CAS has partnered for
decades with Chinese organizations, including the State Intellectual Property
Office of the People's Republic of China (SIPO), to build its information

About CAS

Chemical Abstracts Service (CAS), a division of the American Chemical
Society, is the world's authority for chemical information. Our databases are
curated and quality-controlled by CAS scientists, and recognized by chemical
and pharmaceutical companies, universities, government organizations, and
patent offices around the world as comprehensive and authoritative. By
combining these databases with advanced search and analysis technologies
(SciFinder, STN(R), and Science IP(R) products and services), CAS delivers
the most current, complete, and cross-linked secure digital information
environment for scientific discovery.

About WuXi PharmaTech

WuXi PharmaTech is a leading pharmaceutical, biotechnology, and medical
device R&D outsourcing company, with operations in China and the United
. As a research-driven and customer-focused company, WuXi PharmaTech
provides a broad and integrated portfolio of laboratory and manufacturing
services throughout the drug and medical device R&D process. WuXi
PharmaTech's services are designed to assist its global partners in
shortening the cycle and lowering the cost of drug and medical device R&D.
WuXi PharmaTech's operating subsidiaries are known as WuXi AppTec. For more
information, please visit www.wuxiapptec.com.

Donna Jenkins of CAS, +1-614-447-3727, cas-pr at cas.org

will not be displayed